A Psoriasis Gene Emerges

IL-36–Receptor Antagonist Deficiency Causes Generalized Pustular Psoriasis

Kenneth Y. Tsai, MD, PhD


Journal Watch 

In This Article

Abstract and Introduction


The first single-gene mutation to be directly implicated in psoriasis presents a potential target for intervention.


Generalized pustular psoriasis (GPP) is an episodic, multisystem, inflammatory disorder characterized by fever, leukocytosis, disseminated pustules, and considerable mortality. To identify the disease's genetic basis, researchers studied nine Tunisian families with an autosomal recessive predisposition to GPP.

The investigators identified an area of homozygosity at chromosome 2q13-14 in all affected individuals. In this area of the genome, which contains many genes governing cytokine function and regulation, they identified a mutation that affects the interleukin (IL)-36–receptor antagonist IL-36Ra, weakening the protein and compromising its function.

IL-36Ra is an endogenous antagonist of the IL-36α, β, and γ inflammatory cytokines that normally activate nuclear factor-κB and mitogen-activated protein kinase pathways. Keratinocytes from affected patients produced more IL-8 in response to diverse immune- activating stimuli, and lesional patient skin had elevated levels of multiple inflammatory cytokines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.